# Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates

> **NCT00986947** · PHASE2 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 20 (actual)

## Conditions studied

- Kidney Failure

## Interventions

- **DRUG:** IVIg and rituximab

## Key facts

- **NCT ID:** NCT00986947
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00986947

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00986947, "Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00986947. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*